Status:
COMPLETED
Medication Review Improves Pain Management and Quality of Life in Chronic Pain
Lead Sponsor:
Polytechnic Institute of Porto
Collaborating Sponsors:
University of Salamanca
Conditions:
Chronic Pain
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The goal of this parallel-group, single-blinded, randomized study is to conduct Medication Review (MR) Type III in chronic non-cancer pain patients to optimize drug therapy and measure it's influence ...
Eligibility Criteria
Inclusion
- Non-cancer chronic pain (\>3 months, any cause)
- Follow-up at one of the selected Primary Care Units
- Average weekly pain score ≥4 at the screening phase
- Ability to attend monthly in-person or video interviews
Exclusion
- Pregnancy
- Breastfeeding
- Dementia
- Other mental illness impairing self-reporting
Key Trial Info
Start Date :
November 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 26 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06997861
Start Date
November 3 2023
End Date
June 26 2024
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de Investigação em Saúde e Ambiente (CISA) - School of Health of the Polytechnic Institute of Porto
Porto, Portugal, 4200-072